Journal Information
Vol. 26. Issue 6.
Pages 244-247 (August - September 1990)
Share
Share
Download PDF
More article options
Vol. 26. Issue 6.
Pages 244-247 (August - September 1990)
Full text access
Tratamiento quirúrgico del carcinoma bronquial N2 no oat-cell asociado a linfadenectomía radical mediastínica
Surgical treatment of non oat-cell N2 bronchogenic carcinoma associated with radical mediastinal lymphadenectomy
Visits
3479
J. Zapatero Gaviria, R. Peñalver Pascual, M. Córdoba Peláez, B. Baschwitz Gomez, L. Madrigal Royo, J. Lago Viguera, J. Candelas Barrios
Servicios de Cirugía Torácica, Hospital Ramón y Cajal. Madrid
A. Golpe Gomez*, E. Pérez Rodríguez*, C. Casanova Macario*, S. Dominguez Reboiras*
* Neumología. Hospital Ramón y Cajal. Madrid
This item has received
Article information

El tratamiento quirúrgico del cáncer bronquial N2 (ganglios mediastínicos ipsilaterales positivos) ha sido muy cuestionado en los últimos años, existiendo posturas contradictorias al respecto. Los autores revisan 27 casos N2 resecados, asociando radioterapia y/o poliquimioterapia adyuvantes, obteniendo una supervivencia actuarial de un 24% a los tres años, frente a un 7% a los tres años para los casos irresecables y no intervenidos.

El factor N2 conlleva un pronóstico postoperatorio más grave con respecto al N0 y N1 (p < 0,05). La quimioterapia neoadyuvante ha cambiado en los últimos años el manejo de estos pacientes, aumentando las tasas de resecabilidad y supervivencia.

The surgical treatment of the N2 bronchogenic carcinoma (positive ipsilateral mediastinal lymph nodes) has been recently questioned and controversial positions have been adopted. The authors review 27 cases of N2 which have been surgically resected and treated with the association of radiotherapy and, or, with polychemotherapy. The actuarial survival after three years was 24% for the resected cases and 7% for the nonoperated patients.

The N2 factor carries a more serious postoperative prognosis than N0 and N1 (p < 0,05). The concurrent chemotherapy has improved in the last years the rates of resectability and survival.

Full text is only aviable in PDF
Bibliografía
[1.]
G. Deneffe, L.M. Lacquet, E. Verbeken, G. Vermaut.
Surgical treatment of bronchogenic carcinoma; a retrospective study of 720 thoracotomies.
Ann Thorac Surg, 45 (1988), pp. 380-383
[2.]
T. Naruke, T. Goya, R. Tsuchiya, K. Suemasu.
The importance of surgery of non-small cell carcinoma of lung with mediastinal lymph node metastases.
Ann Thorac Surg, 46 (1988), pp. 603-610
[3.]
L.H. Einhorn.
Neoadjuvant therapy of stage III non small cell lung cancer.
Ann Thorac Surg, 46 (1988), pp. 362-365
[4.]
C.L. Backer, T.W. Shields, E. Lockhart, R. Vogelzang, J. Lo Cicero.
Selective preoperative evaluation for possible N2 disease in carcinoma of the lung.
J Thorac Cardiovasc Surg, 93 (1987), pp. 337-343
[5.]
R.H. Breyer, N. Karstaedt, S.A. Mills.
Computed tomography for evaluation of mediastinal lymph nodes in lung cancer; correlation with surgical staging.
Ann Thorac Surg, 38 (1984), pp. 215-220
[6.]
W.G. Graves, M.J. Martinez, P.L. Carter, M.J. Barry, J.S. Clarke.
The value of computed tomography in staging bronchogenic carcinoma: a changing role for mediastinoscopy.
Ann Thorac Surg, 40 (1985), pp. 57-59
[7.]
C.F. Mountain.
Prognostic implications of the International Staging System for Lung Cancer.
Semin Oncol, 15 (1988), pp. 236-245
[8.]
The Lung Cancer Study Group. Thomas PA, Piantadosi S Mountain CF. Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer?.
J Thorac Cardiovasc Surg, 95 (1988), pp. 883-887
[9.]
N. Martini, E.J. Beattie.
Current views in primary pulmonary cancer.
Int Adv Surg Oncol, 3 (1980), pp. 275-297
[10.]
R. Feld, R.J. Ginsberg.
Update in lung cancer.
Lung Cancer, 2 (1986), pp. 7-16
[11.]
J. Gaer, P. Goldstraw.
Intraoperative assessment of nodal staging in carcinoma of the bronchus.
Thorax, 40 (1985), pp. 700
[12.]
M.M. Kirsh, H. Sloan.
Mediastinal metastases in bronchogenic carcinoma: influence of postoperative irradiation, cell type and location.
Ann Thorac Surg, 33 (1982), pp. 459-463
[13.]
F.G. Pearson, N.C. Delarue, R. Ilves, T.R.J. Todd, J.D. Cooper.
Significance of positive superior mediastinal nodes indentified at mediastinoscopy in patients with resectable cancer of the lung.
J Thorac Cardiovasc Surg, 83 (1982), pp. 1-11
[14.]
G.A. Patterson, D. Piazza, F. Pearson, et al.
Significance of metastatic disease in subaortic lymph nodes.
Ann Thorac Surg, 43 (1987), pp. 155-159
[15.]
Y. Kenis.
Surgical adjuvant chemotherapy in non-small cell carcinoma of the lung.
Int J Radiat Oncol Biol Phys, 6 (1980), pp. 1.075-1.077
[16.]
G. Bonadonna.
Surgical adjuvant chemotherapy for carcinomas.
Antibiot Chemother, 24 (1978), pp. 83-94
[17.]
N. Martini, M.G. Kris, R.J. Gralla, et al.
The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2M0).
Ann Thorac Surg, 45 (1988), pp. 370-379
[18.]
N. Martini, B.J. Flehinger, M.B. Zaman, E.J. Beattie.
Results of resection in non-small cell carcinoma of the lung with mediastinal lymph node metastases.
Ann Surg, 198 (1983), pp. 386-397
[19.]
A.D. Steinfeld, A.S. Glicksman.
Postoperative adjuvant mediastinal radiation in lung cancer.
J Surg Oncol, 26 (1984), pp. 154-157
[20.]
N.C. Choi.
Reassessment of the role of postoperative radiation therapy in resected lung cancer.
Int J Radiat Oncol Biol Phys, 8 (1982), pp. 2.015-2.018
Copyright © 1990. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?